CompanyGraph
What stands out
- Most companies in its industry are production businesses; this one is a sense-making business
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleRevenue is $830.26M, above the global median of $520.53M
- FinancialsAltman Z-Score 0.36: distress zone
- Interpretations1 currently firing — 1
What this company is and how it runs — written from structure, not news.
What stands out
- Most companies in its industry are production businesses; this one is a sense-making business
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
589.95MEUR682.86M · vs all stocks (USD)
Revenue (TTM)
717.28MEUR830.26M · vs all stocks (USD)
Profit Margin
-27.47%Beta
1.26xvs all stocks
52-Week Change
-46.58%vs all stocks
Market Capitalization
589.95MEUR682.86M · vs all stocks (USD)
Enterprise Value
600.16MEUR694.68M · vs all stocks (USD)
Forward P/E
-7.95xPrice to Sales (TTM)
0.8225xPrice to Book (MRQ)
0.8426xEnterprise to Revenue
0.8370xEnterprise to EBITDA
-8.20xGross Margin
-1.00%Profit Margin
-27.47%Operating Margin
-62.26%Return on Assets (TTM)
-5.39%Return on Equity (TTM)
-26.07%Revenue (TTM)
717.28MEUR830.26M · vs all stocks (USD)
Revenue per Share (TTM)
4.04EURUpdated Aug 19, 2026Quarterly Revenue Growth
-16.20%Gross Profit (TTM)
60.71MEUR70.27M · vs all stocks (USD)
EBITDA (TTM)
28.23MEUR32.67M · vs all stocks (USD)
Net Income (TTM)
-197.05MEUR-228.08M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-21.67%Operating Cash Flow (TTM)
-115.03MEUR-133.15M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-80.99MEUR-93.75M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.00EURUpdated Aug 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Revenue
788.37MEURFY2025 · Dec 31, 2025Cost of Goods Sold
674.15MEURFY2025 · Dec 31, 2025Gross Profit
114.22MEURFY2025 · Dec 31, 2025Operating Income
-55.82MEUR-64.61M · vs all stocks (USD)
Pre-tax Income
-86.77MEURFY2025 · Dec 31, 2025Income Tax Expense
16.75MEURFY2025 · Dec 31, 2025Net Income
-103.52MEURFY2025 · Dec 31, 2025EBIT
-72.32MEURFY2025 · Dec 31, 2025EBITDA (Income Statement)
28.23MEURFY2025 · Dec 31, 2025Research & Development
37.51MEURFY2025 · Dec 31, 2025Selling, General & Administrative
175.97MEURFY2025 · Dec 31, 2025Other Operating Expenses
-1.83MEURFY2025 · Dec 31, 2025Non-operating Interest Income
4.42MEURFY2025 · Dec 31, 2025Non-operating Interest Expense
14.44MEURFY2025 · Dec 31, 2025EPS (Basic)
-0.5800EURFY2025 · Dec 31, 2025EPS (Diluted)
-0.5800EURFY2025 · Dec 31, 2025Basic Shares Outstanding
177.58MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
177.58MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-103.52MEURFY2025 · Dec 31, 2025Operating Cash Flow
-15.33MEURFY2025 · Dec 31, 2025Free Cash Flow
-87.65MEURFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
418.52MEURFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-103.52MEURFY2025 · Dec 31, 2025Depreciation & Amortization
99.48MEURFY2025 · Dec 31, 2025Deferred Taxes (CF)
16.75MEURFY2025 · Dec 31, 2025Stock-based Compensation
3.78MEURFY2025 · Dec 31, 2025Other Non-cash Items
28.99MEURFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-28.73MEURFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-7.30MEURFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-24.77MEURFY2025 · Dec 31, 2025Capital Expenditures
-72.33MEURFY2025 · Dec 31, 2025Net Intangibles (CF)
-10.08MEURFY2025 · Dec 31, 2025Net Acquisitions
216.86MEURFY2025 · Dec 31, 2025Purchase of Investments
0.00EURFY2025 · Dec 31, 2025Sale of Investments
31.97MEURFY2025 · Dec 31, 2025Other Investing Activity
1.00KEURFY2025 · Dec 31, 2025Net Investing Cash Flow
176.50MEURFY2025 · Dec 31, 2025Long-term Debt Issuance
43.96MEURFY2025 · Dec 31, 2025Long-term Debt Payments
-73.38MEURFY2025 · Dec 31, 2025Common Stock Repurchase
-1.55MEURFY2025 · Dec 31, 2025Common Dividends Paid
0.00EURFY2025 · Dec 31, 2025Other Financing Charges
-1.46MEURFY2025 · Dec 31, 2025Net Financing Cash Flow
-32.43MEURFY2025 · Dec 31, 2025Shares Outstanding
177.59MSharesUpdated Aug 19, 2026Float Shares
135.39MSharesUpdated Aug 19, 2026% Held by Insiders
9.97%vs all stocks
% Held by Institutions
61.27%vs all stocks
Total Cash (MRQ)
465.59MEUR538.92M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.62EURUpdated Aug 19, 2026Total Debt (MRQ)
475.87MEUR550.81M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.7150xCurrent Ratio (MRQ)
2.33xBook Value per Share (MRQ)
3.94EURUpdated Aug 19, 2026Total Assets
1.71BEUR1.98B · vs all stocks (USD)
Total Current Assets
762.95MEURFY2025 · Dec 31, 2025Total Liabilities
900.24MEURFY2025 · Dec 31, 2025Total Non-current Assets
951.00MEURFY2025 · Dec 31, 2025Total Non-current Liabilities
532.17MEURFY2025 · Dec 31, 2025Total Current Liabilities
368.07MEURFY2025 · Dec 31, 2025Cash
167.73MEURFY2025 · Dec 31, 2025Cash Equivalents
234.06MEURFY2025 · Dec 31, 2025Cash & Cash Equivalents
401.79MEURFY2025 · Dec 31, 2025Other Short-term Investments
61.23MEURFY2025 · Dec 31, 2025Accounts Receivable
135.96MEURFY2025 · Dec 31, 2025Inventory
29.32MEURFY2025 · Dec 31, 2025Accounts Payable
64.76MEURFY2025 · Dec 31, 2025Short-term Debt
103.68MEURFY2025 · Dec 31, 2025Deferred Revenue
108.07MEURFY2025 · Dec 31, 2025Other Current Liabilities
11.10MEURFY2025 · Dec 31, 2025Long-term Debt
344.01MEURFY2025 · Dec 31, 2025Other Non-current Liabilities
1.72MEURFY2025 · Dec 31, 2025Common Stock (Book)
177.78MEURFY2025 · Dec 31, 2025Retained Earnings
-775.89MEURFY2025 · Dec 31, 2025Total Shareholders' Equity
813.70MEUR941.86M · vs all stocks (USD)
Treasury Stock
1.55MEURFY2025 · Dec 31, 202552-Week Low
3.18EURUpdated Aug 19, 202652-Week High
7.30EURUpdated Aug 19, 202652-Week Change
-46.58%vs all stocks
Beta
1.26xvs all stocks
50-Day MA
4.19EURUpdated Aug 19, 2026200-Day MA
5.06EURUpdated Aug 19, 2026Avg 10-Day Volume
916.64KSharesUpdated Aug 19, 2026Avg 30-Day Volume
1.10MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
-1.11EURUpdated Aug 19, 2026Other Income / Expense
-20.93MEURFY2025 · Dec 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Most companies in its industry are production businesses; this one is a sense-making businessSignificant
Industry peers: 330Share on the common pattern %: 99.00
Looks liquid, but the distress score says otherwiseNotable
Current Ratio: 2.33Altman Z-Score: 0.36
Financial Health
Altman Z-Score 0.36: distress zoneCritical
Altman Z-Score: 0.36
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Revenue is $830.26M, above the global median of $520.53MNotable
Revenue (USD): 830,255,081.76Global Median: 520,528,949.311
Companies that share the same coordination system — how they create, deliver, or capture value.
Fortrea Holdings Inc.
Tier 1SenseMakingApproval-Gated PipelineFlowInterface
Shanghai Medicilon Inc.
Tier 1SenseMakingApproval-Gated PipelineProduction
Caris Life Sciences, Inc.
Tier 1SenseMakingApproval-Gated PipelineProductionInterface
Hvivo Plc
Tier 1SenseMakingApproval-Gated PipelineProductionRule
Ixico plc
Tier 1SenseMakingApproval-Gated PipelineProductionInterface
Fusion Antibodies Ltd.
Tier 1SenseMakingApproval-Gated PipelineProduction
Beijing ZZNode Technologies Co., Ltd.
Tier 3SenseMakingExpertise LeverageProductionFlow
Jiangsu Chuanzhiboke Education Technology Co., Ltd.
Tier 3SenseMakingThroughput-Bound ConversionAttentionInterface
Funai Soken Holdings Inc.
Tier 3SenseMakingExpertise LeverageInterfaceRule
Stadio Holdings Ltd.
Tier 3SenseMakingExpertise LeverageProductionRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Shandong Longda Meishi Co., Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Shanghai Geoharbour Construction Group Co. Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated